Wada satisfied over Froome exemption

A special exemption for Chris Froome to take steroids ahead of this year’s Tour de Romandie followed correct procedure, the World Anti-Doping Agency has said.

A French newspaper last week claimed the International Cycling Federation (UCI) failed to refer the request to the relevant committee.

Wada on Tuesday said it was “satisfied” the correct steps had been followed.

What is prednisolone?

Prednisolone is a medicine used in inflammatory and allergic disorders. It is a corticosteroid and works by preventing or reducing inflammation. It is used to treat a number of conditions that are characterised by excessive inflammation.

Corticosteroid are prohibited when administered by oral, intravenous, intramuscular or rectal routes, but exemption requests may be made.

Sources: nhs.uk; wada-ama.org.

Team Sky had asked the UCI to grant a therapeutic use exemption (TUE) after Froome contracted a chest infection.

Le Journal du Dimanche newspaper had asserted that Team Sky’s request for Froome to take corticosteroid prednisolone ahead of the race at the end of April was authorised by the UCI medical supervisor without referring the case to the TUE committee.

However, a Wada statement said it was “satisfied that the UCI’s decision to grant a Therapeutic Use Exemption to Chris Froome was conducted according to the rules of the International Standard for Therapeutic Use Exemptions, and therefore will not be reviewing this case any further”.

The UCI has also looked into the newspaper’s claims and in a statement on Sunday said “nothing out of the ordinary occurred” in the process to grant an exemption.

Froome,

the reigning Tour de France champion,

overcame his illness to

win Tour de Romandie for the second year in succession.

Article source: http://www.bbc.co.uk/sport/0/cycling/27882004

Comments are closed.

Johnny’s favourite stores



Archives